167 related articles for article (PubMed ID: 27239928)
1. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease].
Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV
Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
[TBL] [Abstract][Full Text] [Related]
3. [The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease].
Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV; Scuderi A; Antignani PL
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):28-35. PubMed ID: 28805757
[TBL] [Abstract][Full Text] [Related]
4. [The use of cytoflavin in sports nutrition].
Kosinets VA; Stolbitskiĭ VV; Shturich IP
Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
[TBL] [Abstract][Full Text] [Related]
5. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
[TBL] [Abstract][Full Text] [Related]
6. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of cognitive dysfunction in elderly cancer patients operated on the pelvic organs in conditions of multimodal anesthesia].
Tumanyan SV; Shepelenko AV; Chekmezova SA
Khirurgiia (Mosk); 2018; (11):44-48. PubMed ID: 30531753
[TBL] [Abstract][Full Text] [Related]
9. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
10. [Dynamics of indicators of the functional state of the central nervous system in Navy operators treated with cytoflavin after a long working cycle].
Parfenov SA; Belov VG; Parfenov YA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):55-58. PubMed ID: 28884718
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the effects of cytoflavin on symptoms of depression and autonomic dysfunction in patients with organic depressive disorder].
Gudkova AN; Osinovskaia NA; Polunina AG; Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):50-5. PubMed ID: 24430035
[TBL] [Abstract][Full Text] [Related]
12. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin].
Kartashova EA; Romantsov MG; Sarvilina IV
Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of metabolic treatment in the early recovery period of patients with ischemic stroke].
Poltavskaya TS; Bazhenov VA; Volojanin AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):49-53. PubMed ID: 32307430
[TBL] [Abstract][Full Text] [Related]
14. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
Sazonov IE; Kudinov AA; Fedotova EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
[TBL] [Abstract][Full Text] [Related]
15. [Cytoflavin® effect on endothelium function and cerebral hemodynamics in patients with hypertensive enceplalopathy].
Belova LA; Mashin VV; Kolotik-Kameneva OY; Proshin AN
Antibiot Khimioter; 2014; 59(7-8):30-6. PubMed ID: 25975105
[TBL] [Abstract][Full Text] [Related]
16. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
[TBL] [Abstract][Full Text] [Related]
17. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
[TBL] [Abstract][Full Text] [Related]
18. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy].
Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN
Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
20. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
